Freshpaint vs Amgen
Side-by-side comparison of AI visibility scores, market position, and capabilities
HIPAA-compliant analytics infrastructure for healthcare; strips PHI from tracking events before reaching Google Analytics, Meta, or other marketing tools.
About
Freshpaint is a healthcare data privacy and analytics infrastructure platform that enables digital health companies and hospitals to run marketing analytics and tracking without violating HIPAA. Founded in 2019 and headquartered in San Francisco, Freshpaint solves a critical compliance challenge: standard web analytics tools (Google Analytics, Meta Pixel, Mixpanel) capture Protected Health Information (PHI) when embedded on healthcare websites, creating HIPAA liability. Freshpaint intercepts and sanitizes tracking events before they reach third-party analytics vendors.
Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.
About
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.